TITLE

Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor

PUB. DATE
January 2008
SOURCE
BMC Genetics;2008, Vol. 9, p354
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43750518

 

Related Articles

  • Interleukin-1β Increases Airway Epithelial Cell Mitogenesis Partly by Stimulating Endothelin-1 Production. Murlas, C.G.; Sharma, A.C.; Gulati, A.; Najmabadi, F. // Lung;1997, Vol. 175 Issue 2, p117 

    To investigate the influence of interleukin-1β (IL-1β) on airway epithelial cell growth, we measured [ ³H]thymidine incorporation and cell numbers of cultured porcine tracheal epithelial cells in the presence or absence of human recombinant IL-1β with or without the following:...

  • Interactions of Prostacyclin and Endothelin. Clapp, Lucie // Current Medical Literature: Pulmonary Hypertension;2012 Supplement, p2 

    The article explores the health benefits of a combination of endothelin receptor antagonists (ERAs) and prostacyclin therapy. It mentions a study conducted by the author and colleagues which tries to culture pulmonary smooth muscle cells from idiopathic pulmonary arterial hypertension (PAH)...

  • Macitentan: Endothelin receptor antagonist. Sheffer, Joe // Pharmacy Today;Dec2013, Vol. 19 Issue 12, p50 

    Information on Macitentan, an endothelin receptor antagonist (ERA) with the trade Opsumit (Actelion), is presented.

  • Addition of novel PCa agent to taxane shows benefit. Bankhead, Charles // Urology Times;8/1/2006, Vol. 34 Issue 9, p26 

    The article presents a study according to which combining endothelin A receptor antagonist atrasentan with taxane chemotherapy is effective against prostate cancer. Prostate cancer cells treated with the combination of atrasentan and docetaxel/paclitaxel shown a decrease in the cell population...

  • Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat. Henriksson, Marie; Stenman, Emelie; Vikman, Petter; Edvinsson, Lars // BMC Neuroscience;2007, Vol. 8, p1 

    Background: Protein kinase C (PKC) is known to be involved in the pathophysiology of experimental cerebral ischemia. We have previously shown that after transient middle cerebral artery occlusion, there is an upregulation of endothelin receptors in the ipsilateral middle cerebral artery. The...

  • Endothelin Receptor Antagonists: Structures, Synthesis, Selectivity and Therapeutic Applications. Boss, C.; Bolli, M.; Weller, T. // Current Medicinal Chemistry;Feb2002, Vol. 9 Issue 3, p349 

    Endothelin (ET) was discovered in 1988 and is the most potent vasoconstrictive peptide known to date. It exists in three isoforms (ET-1 to ET-3) and acts on two endothelin receptor subtypes, the endothelin-A (ETA)-receptor and the endothelin-B (ETB)-receptor. Endothelin receptor antagonists are...

  • Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening. Holzhauser, Luise; Zolty, Ronald // Heart Failure Reviews;Nov2014, Vol. 19 Issue 6, p743 

    Since its discovery in 1988, the endothelin system has been employed in multiple physiological and pathological roles. Endothelin-1 (ET-1) is not only a major regulator of vascular tone and cardiac contractility but also exerts mitogenic effects and is involved in inflammatory responses. ET-1...

  • Ambrisentan for pulmonary fibrosis. Punwani, Ravi // Thorax;May2014, Vol. 69 Issue 5, p489 

    In this article, the author focuses on effectiveness of drug ambrisentan, an endothelin A receptor antagonist, in the treatment of idiopathic pulmonary fibrosis (IPF) progression. The author mentions a follow up study for comparing ambrisentan as endothelin receptor blockade decreased the...

  • Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Yuen, Tracy J.; Johnson, Kory R.; Miron, Veronique E.; Zhao, Chao; Quandt, Jacqueline; Harrisingh, Marie C.; Swire, Matthew; Williams, Anna; McFarland, Henry F.; Franklin, Robin J. M.; ffrench-Constant, Charles // Brain: A Journal of Neurology;Apr2013, Vol. 136 Issue 4, p1035 

    The development of new regenerative therapies for multiple sclerosis is hindered by the lack of potential targets for enhancing remyelination. The study of naturally regenerative processes such as the innate immune response represents a powerful approach for target discovery to solve this...

  • D3 Dopamine Receptor and Essential Hypertension. Zeng, Chunyu; Eisner, Gilbert M.; Felder, Robin A.; Jose, Pedro A. // Current Hypertension Reviews;2006, Vol. 2 Issue 3, p247 

    Dopamine receptors are expressed in a number of organs and tissues; the peripheral dopamine receptors influence cardiovascular and renal function by decreasing preload and afterload and by regulating fluid and electrolyte transport. Most of the knowledge on these actions of dopamine has been...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics